Facebook
X
LinkedIn
ForwardSeptember 20 - 21, 2014 - Hyatt Regency, St. Louis, MO
Course Directors: Karon, Barry L., M.D. | Bremer, Merri L., R.N., R.D.C.S.
Program Schedule
Program schedules are subject to change without notice.
Saturday, September 20
| Time | Topic |
|---|---|
| 6:30 a.m. | Registration – Continental Breakfast |
| 7:00 a.m. | Welcome, Course Overview, and Orientation to the Audience Response System FOCUS ON VENTRICULAR FUNCTION |
| 7:15 a.m. | Doppler Hemodynamic Assessment: Principles, Formulae, and Calculations Barry L. Karon, M.D. |
| 7:40 a.m. | Assessment of Left Ventricular Systolic Function: 2-D, 3-D, and Doppler Parameters Jennifer L. Betz, R.D.C.S. |
| 8:05 a.m. | Myocardial Strain Imaging Leslie A. Elvert, B.S., R.D.C.S. |
| 8:30 a.m. | Echocardiographic Assessment of Diastolic Function Merri L. Bremer, R.N., R.D.C.S. |
| 9:00 a.m. | Assessment of Right Ventricular Systolic Function: 2-D, M-Mode, and Doppler Parameters Sabrina D. Phillips, M.D. |
| 9:30 a.m. | Discussion / Questions and Answers Faculty |
| 9:40 a.m. | Refreshment Break FOCUS ON VALVULAR STENOSIS |
| 10:00 a.m. | Pathology of Aortic and Mitral Stenosis William D. Edwards, M.D. |
| 10:30 a.m. | Cases in Aortic Stenosis: 2-D/Doppler Assessment and Quantitation of Severity Sabrina D. Phillips, M.D. |
| 11:00 a.m. | Cases in Mitral Stenosis: 2-D/Doppler Assessment and Quantitation of Severity Rekha Mankad, M.D. |
| 11:30 a.m. | Stress Echo for Valvular Stenosis (including MS, low-output AS) Benjamin F. Wong, M.D. |
| 11:50 a.m. | Discussion / Questions and Answers Faculty |
| 12:00 p.m. | Lunch FOCUS ON VALVULAR REGURGITATION AND PROTHESES |
| 1:00 p.m. | Pathology of Mitral and Aortic Regurgitation William D. Edwards, M.D. |
| 1:25 p.m. | Mitral and Aortic Regurgitation: Semi-Quantitative Assessment by Doppler and Color Flow Imaging Merri L. Bremer, R.N., R.D.C.S. |
| 1:50 p.m. | Quantitative Assessment of Valvular Regurgitation by PISA and Continuity Methods Leslie A. Elvert, B.S., R.D.C.S. |
| 2:15 p.m. | Discussion / Questions and Answers Faculty |
| 2:25 p.m. | Refreshment Break |
| 2:40 p.m. | Cases in Valvular Regurgitation Jennifer L. Betz, R.D.C.S., Leslie A. Elvert, B.S., R.D.C.S., and Barry L. Karon, M.D. |
| 3:10 p.m. | Cases in Prosthetic Valves: Assessment of Normal Prosthetic Function and Dysfunction Rekha Mankad, M.D. |
| 3:40 p.m. | Prosthesis-Patient Mismatch Benjamin F. Wong, M.D. |
| 4:00 p.m. | Adjourn |
Sunday, September 21
| Time | Topic |
|---|---|
| 7:00 a.m. | Continental Breakfast |
| 7:30 a.m. | Ergonomics for Sonographers Merri L. Bremer, R.N., R.D.C.S. |
| 8:00 a.m. | Echo Assessment of Tricuspid and Pulmonic Valve Disease Jennifer L. Betz, R.D.C.S. |
| 8:30 a.m. | Congenital Heart Disease (That Arrives Unannounced) Sabrina D. Phillips, M.D. |
| 9:00 a.m. | Discussion / Questions and Answers Faculty |
| 9:15 a.m. | Refreshment Break |
| 9:30 a.m. | Cases in Endocarditis Benjamin F. Wong, M.D. |
| 10:00 a.m. | Interventional Echocardiography for Valvular Disease Rekha Mankad, M.D. |
| 10:30 a.m. | Echo Unknowns (You Can’t Afford to Miss) William D. Edwards, M.D. and Barry L. Karon, M.D. |
| 11:15 a.m. | Lunch – Working Lunch |
| 11:30 a.m. | Echo Lab Accreditation: What’s New? Merri L. Bremer, R.N., R.D.C.S. |
| 12:00 p.m. | Echo Detectives: An Interactive, Case-based Approach to Evaluation of Valvular Pathology All Faculty |
| 2:00 p.m. | Adjourn |
Faculty
Course Directors
- Merri L. Bremer, R.N., R.D.C.S.
- Barry L. Karon, M.D.
Mayo Clinic Faculty
- Jennifer L. Betz, B.S., R.D.C.S.
- William D. Edwards, M.D.
- Leslie A. Elvert, B.S., R.D.C.S.
- Rekha Mankad, M.D.
- Sabrina D. Phillips, M.D.
- Benjamin F. Wong, M.D.
Faculty Disclosure
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.